Your browser doesn't support javascript.
loading
Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data.
Norvang, Vibeke; Haavardsholm, Espen A; Tedeschi, Sara K; Lyu, Houchen; Sexton, Joseph; Mjaavatten, Maria D; Kvien, Tore K; Solomon, Daniel H; Yoshida, Kazuki.
Afiliação
  • Norvang V; Division of Rheumatology and Research, Diakonhjemmet Hospital, Box 23 Vinderen, 0319, Oslo, Norway. v.norvang@gmail.com.
  • Haavardsholm EA; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, USA. v.norvang@gmail.com.
  • Tedeschi SK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Box 23 Vinderen, 0319, Oslo, Norway.
  • Lyu H; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Sexton J; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, USA.
  • Mjaavatten MD; Harvard Medical School, Boston, USA.
  • Kvien TK; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, USA.
  • Solomon DH; Department of Orthopedics, Chinese PLA General Hospital, Beijing, China.
  • Yoshida K; Division of Rheumatology and Research, Diakonhjemmet Hospital, Box 23 Vinderen, 0319, Oslo, Norway.
BMC Med Res Methodol ; 22(1): 152, 2022 05 28.
Article em En | MEDLINE | ID: mdl-35643430
BACKGROUND: Observational data are increasingly being used to conduct external comparisons to clinical trials. In this study, we empirically examined whether different methodological approaches to longitudinal missing data affected study conclusions in this setting. METHODS: We used data from one clinical trial and one prospective observational study, both Norwegian multicenter studies including patients with recently diagnosed rheumatoid arthritis and implementing similar treatment strategies, but with different stringency. A binary disease remission status was defined at 6, 12, and 24 months in both studies. After identifying patterns of longitudinal missing outcome data, we evaluated the following five approaches to handle missingness: analyses of patients with complete follow-up data, multiple imputation (MI), inverse probability of censoring weighting (IPCW), and two combinations of MI and IPCW. RESULTS: We found a complex non-monotone missing data pattern in the observational study (N = 328), while missing data in the trial (N = 188) was monotone due to drop-out. In the observational study, only 39.0% of patients had complete outcome data, compared to 89.9% in the trial. All approaches to missing data indicated favorable outcomes of the treatment strategy in the trial and resulted in similar study conclusions. Variations in results across approaches were mainly due to variations in estimated outcomes for the observational data. CONCLUSIONS: Five different approaches to handle longitudinal missing data resulted in similar conclusions in our example. However, the extent and complexity of missing observational data affected estimated comparative outcomes across approaches, highlighting the need for careful consideration of methods to account for missingness in this setting. Based on this empirical examination, we recommend using a prespecified advanced missing data approach to account for longitudinal missing data, and to conduct alternative approaches in sensitivity analyses.
Assuntos
Palavras-chave

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Modelos Estatísticos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Modelos Estatísticos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article